The Week in Brief
- Russell 2000 gained 1.3% while Nasdaq-100 fell 2.0%; S&P 500 edged down 0.6%
- Health care led all sectors with a 3.1% gain; technology lagged at -2.0%
- ServiceNow Inc fell 33.9% after missing earnings; Intel Corp dropped 24.4% despite a beat
- Replimune Group Inc rose 53.7% to lead all stocks; XP Inc fell 53.0%
Small caps outperformed large caps as the Russell 2000 gained 1.3% while the Nasdaq-100 fell 2.0% and the S&P 500 declined 0.6%. Breadth was positive across the 1,909-stock universe, with 1,129 advancers against 773 decliners and a median stock gain of 0.9%. The divergence between small-cap strength and large-cap tech weakness defined the week's character.
Index & Asset Scoreboard
Weekly price change of the major index and asset-class ETFs, Friday close to Friday close.
| Instrument | Oct 30 close | Week |
|---|---|---|
| S&P 500 (SPY) | $755.72 | ▼-0.56% |
| Nasdaq-100 (QQQ) | $690.49 | ▼-1.97% |
| Dow Jones (DIA) | $517.13 | ▼-0.81% |
| Russell 2000 (IWM) | $279.33 | ▲+1.30% |
| 20+ Yr Treasuries (TLT) | $81.84 | ▲+0.61% |
| Gold (GLD) | $355.78 | ▼-2.95% |
| Crude Oil (USO) | $168.83 | ▼-0.41% |
Sector Rotation
Health care led the sector table with a 3.1% gain while technology lagged at -2.0%. Breadth confirmed the pattern: 176 of 283 health care stocks advanced with an average gain of 2.1%, while just 112 of 260 technology stocks finished higher. Defensive sectors including utilities and consumer staples also posted gains.
Left: the ten SPDR sector ETFs ranked by weekly price change. Right: breadth inside each sector across the screened universe: how many of its stocks rose, and the average move.
| Sector ETF | Week |
|---|---|
| Health Care (XLV) | ▲+3.12% |
| Materials (XLB) | ▲+2.79% |
| Utilities (XLU) | ▲+2.04% |
| Consumer Disc. (XLY) | ▲+2.02% |
| Industrials (XLI) | ▲+1.69% |
| Real Estate (XLRE) | ▲+1.41% |
| Consumer Staples (XLP) | ▲+1.31% |
| Financials (XLF) | ▲+1.09% |
| Energy (XLE) | ▲+1.00% |
| Technology (XLK) | ▼-2.03% |
| Sector (stocks) | Adv / Total | Avg move |
|---|---|---|
| Consumer Discretionary | 142 / 208 | +2.90% |
| Energy | 71 / 97 | +2.29% |
| Materials | 63 / 92 | +2.24% |
| Health Care | 176 / 283 | +2.05% |
| Industrials | 206 / 311 | +1.99% |
| Utilities | 54 / 61 | +1.64% |
| Real Estate | 66 / 107 | +0.90% |
| Consumer Staples | 49 / 86 | -0.01% |
| Financials | 159 / 336 | -0.34% |
| Information Technology | 112 / 260 | -1.27% |
| Communication | 30 / 67 | -1.66% |
Standout Movers
Health care names led the gainers, with Replimune Group Inc rising 53.7% and Surgery Partners Inc gaining 47.4%. Among large caps, Vertiv Holdings Co rose 19.7% after reporting an earnings beat.
ServiceNow Inc fell 33.9% after missing earnings by 3.3%, according to a news report. XP Inc fell 53.0% to lead all decliners, while Intel Corp dropped 24.4% despite beating earnings.
Biggest gainers
Top 10 Winners
Largest weekly gains among US-listed stocks with market cap above $1B and share price above $5. Context shows the week's earnings result and latest headline where available.
Biggest gainers · Oct 23–Oct 30
| Symbol | Week | Context |
|---|---|---|
| REPLReplimune Group Inc$17.61 | ▲+53.66% | — |
| SGRYSurgery Partners Inc$23.21 | ▲+47.37% | — |
| ADTADT Inc$9.86 | ▲+42.90% | — |
| TDOCTeladoc Health Inc$8.51 | ▲+34.23% | EPS beat +29.3% |
| GKOSGlaukos Corp$237.60 | ▲+32.83% | EPS beat +612.0% |
| ULCCFrontier Group Holdings, Inc.$6.45 | ▲+30.57% | EPS beat +680.6% |
| AXGNAxoGen, Inc.$49.37 | ▲+29.72% | EPS beat +47.1% |
| HRIHerc Holdings Inc$165.76 | ▲+29.39% | EPS beat +33.6% |
| HAYWHayward Holdings Inc$16.12 | ▲+27.23% | EPS beat +16.8% |
| OSWOneSpaWorld Holdings Ltd$30.22 | ▲+26.66% | EPS beat +10.1% |
Top 10 Losers
Largest weekly declines on the same screen.
Biggest decliners · Oct 23–Oct 30
| Symbol | Week | Context |
|---|---|---|
| XPXP Inc$14.29 | ▼-53.01% | — |
| IOVAIovance Biotherapeutics Inc$8.48 | ▼-39.82% | — |
| ATECAlphatec Holdings, Inc.$7.04 | ▼-36.63% | EPS miss -6.8% |
| RDDTReddit Inc$91.73 | ▼-36.41% | EPS beat +1.8% |
| NOWServiceNow Inc$105.12 | ▼-33.87% | EPS miss -3.3%As ServiceNow plunges 31%, this mid-cap software stock is surging |
| STNEStoneCo Ltd.$7.75 | ▼-32.49% | — |
| PAGSPagSeguro Digital Ltd$7.94 | ▼-30.59% | — |
| ORICOric Pharmaceuticals Inc$9.24 | ▼-29.84% | — |
| CMPRCimpress PLC$57.02 | ▼-29.09% | EPS miss -113.4% |
| ALNYAlnylam Pharmaceuticals, Inc.$165.00 | ▼-26.35% | EPS beat +885.3% |
Large-Cap Movers
The same ranking restricted to companies above $50B in market cap: the names most likely to sit in index funds and 401(k)s.
Large-cap gainers
- VRTVertiv Holdings Co · $74.8B▲+19.65%
- CVNACarvana Co · $64.7B▲+18.13%
- REGNRegeneron Pharmaceuticals Inc · $82.9B▲+15.26%
- GMGeneral Motors Co · $72.6B▲+15.12%
- PWRQuanta Services Inc · $82.2B▲+13.60%
Large-cap decliners
- NOWServiceNow Inc · $164.4B▼-33.87%
- FTNTFortinet Inc · $125.8B▼-24.40%
- INTCIntel Corp · $491.4B▼-24.38%
- NUNu Holdings Ltd. · $73.2B▼-23.42%
- TEAMAtlassian Corp · $56.3B▼-15.77%
Earnings Movers
Earnings reactions were mixed, with beats sometimes rewarded and sometimes ignored. Glaukos Corp rose 32.8% after a 612.0% earnings surprise, while Intel Corp fell 24.4% despite a 30.1% beat. Among the 522 screened companies that reported, post-earnings moves reflected guidance and forward outlooks as much as the quarter itself.
522 companies in the screen reported quarterly results this week. These are the largest weekly moves among them, with the EPS surprise that accompanied them.
Biggest gains after reporting
| Symbol | Act / Est | Surprise | Week |
|---|---|---|---|
| TDOCTeladoc Health Inc | $-0.15$-0.21 | +29.3% | ▲+34.23% |
| GKOSGlaukos Corp | $0.47$-0.09 | +612.0% | ▲+32.83% |
| ULCCFrontier Group Holdings, Inc. | $0.18$-0.03 | +680.6% | ▲+30.57% |
| AXGNAxoGen, Inc. | $0.21$0.14 | +47.1% | ▲+29.72% |
| HRIHerc Holdings Inc | $3.91$2.93 | +33.6% | ▲+29.39% |
Biggest declines after reporting
| Symbol | Act / Est | Surprise | Week |
|---|---|---|---|
| ATECAlphatec Holdings, Inc. | $0.09$0.10 | -6.8% | ▼-36.63% |
| RDDTReddit Inc | $1.40$1.37 | +1.8% | ▼-36.41% |
| NOWServiceNow Inc | $1.00$1.03 | -3.3% | ▼-33.87% |
| CMPRCimpress PLC | $-0.11$0.82 | -113.4% | ▼-29.09% |
| ALNYAlnylam Pharmaceuticals, Inc. | $16.26$1.65 | +885.3% | ▼-26.35% |
Analyst Sentiment Shifts
Week-over-week change in the share of analysts rating a stock Buy or Strong Buy (minimum five covering analysts).
Buy share rising
| Symbol | Analysts | Buy share now | Change (pp) |
|---|---|---|---|
| LLYVKFormula One Group | 9 | 88.9% | ▼-5.6% |
Buy share falling
| Symbol | Analysts | Buy share now | Change (pp) |
|---|---|---|---|
| LLYVKFormula One Group | 9 | 88.9% | ▼-5.6% |
Methodology & Disclaimer
Data. All figures come from Money365.Market's own daily price, earnings and analyst-recommendation records, captured at each US close. Returns are price returns from the Oct 23 close to the Oct 30 close; dividends are excluded.
Screen. 1,909 US-listed common stocks with market capitalization of at least $1B and a closing price of at least $5, with prices on at least three of the week's 5 trading days. ETFs and funds are excluded from the stock rankings.
Adjustments. Weekly moves are compounded from daily changes and cross-checked against closing prices; where the two disagree (stock splits, data corrections) the smaller move is used and the row is marked with an asterisk.
Narrative. The short prose sections were drafted by an AI model from the verified data above only, then checked automatically for number and ticker traceability, editorial tone and FCA financial-promotion wording before publication.
Important Disclaimer — Not Investment Advice
Disclaimer: This article is provided by Money365.Market for general information and educational purposes only. It is not financial advice, a personal recommendation, or an inducement to buy, sell, or invest in any security or product. Capital is at risk and the value of investments can go down as well as up; past performance does not indicate future results. You should seek independent advice from an FCA-authorised adviser before making any financial decision.
Read the full disclaimer — 8 further points, including total-loss risk, our regulatory status and conflicts of interest
Nothing here is an offer or a solicitation to buy or sell anything, and reading it creates no advisory or fiduciary relationship between you and Money365.Market. Any decision you take is your own.
- You can lose money — including all of it. Individual companies can and do fail, and some of the assets discussed can fall to zero. Only commit money you can afford to lose, and never borrow to invest on the strength of anything you read here.
- Forecasts are opinion, not fact. Any valuation model, scenario, fair-value range, estimate or other forward-looking statement is illustrative, rests on assumptions that may prove wrong, and is never a price target, a forecast of actual outcomes, or a promise of any return.
- Published at a point in time. Figures were believed accurate on the publication or last-updated date shown above and are not maintained afterwards; we are under no obligation to update them. Market and company data comes from third-party sources and is provided without warranty of accuracy, completeness or timeliness.
- Automated content. This brief was compiled by an automated pipeline from validated news and market-data sources and passed through editorial and compliance checks. Automated content can still contain errors — verify anything you intend to rely on.
- We are not regulated. Money365.Market is not authorised or regulated by the UK Financial Conduct Authority, is not registered with the U.S. Securities and Exchange Commission or FINRA as an investment adviser or broker-dealer, and is not a tax adviser. We hold no licence to give personal financial advice and do not do so.
- Interests and independence. Money365.Market is not affiliated with, endorsed by or sponsored by any company, fund, exchange or platform mentioned, and is not paid to feature them. The author may hold positions in securities or assets discussed. The site earns revenue from advertising, subscriptions and, where labelled, affiliate links; this does not influence what we publish.
- Your jurisdiction matters. Tax treatment, contribution limits, product availability and investor protections differ by country and can change. Speak to a qualified tax professional for tax matters, and to a locally licensed adviser if you are outside the UK.
Full terms: Disclaimer · Terms of Service · Privacy Policy